Focus Stocks
Fifth Lilly Oncology on Canvas Art Competition Invites All Touched by Cancer to Share Their Cancer Journeys
Published on Thursday, 09 February 2012 08:16 Written by TradersHuddle Staff
Competition Expands to Canada
INDIANAPOLIS, Feb. 9, 2012 /PRNewswire/ -- Get your canvases, paintbrushes and cameras ready — the subject is cancer and you are the storyteller. Lilly Oncology and the National Coalition for Cancer Survivorship (NCCS) today announced the launch of the 2012 Lilly Oncology On Canvas: Expressions of a Cancer Journey Art Competition and Exhibition. The biennial competition invites individuals from the United States, Puerto Rico and Canada, who were diagnosed with any type of cancer — as well as their families, friends, caregivers and healthcare providers — to express, through art and narrative, the life-affirming changes that give their cancer journeys meaning. Entries must be postmarked by June 29, 2012.
Oncology On Canvas(SM) was launched in 2004 by Lilly Oncology to help those affected by cancer cope with the emotional side of the disease. Winners' prizes consist of donations made to the cancer charities of their choice. Following the competition, much of the artwork embarks on a tour of cancer centers, hospitals and patient advocacy group events.
Since its inception, Lilly Oncology On Canvas has received more than 3,600 entries. However, these 3,600 stories are but a few of the many waiting to be told by the nearly 12 million cancer survivors alive today in the U.S. alone[i] — in addition to millions of others who love and care for them, according to Newt Crenshaw, vice president, Lilly Oncology.
"If you or someone you care for has heard the three words, 'You have cancer,' then you know firsthand that a cancer diagnosis can change the lives of patients and everyone around them," said Crenshaw. "Lilly Oncology On Canvas has become an important way for cancer patients, oncologists, oncology nurses and so many others to share their stories of hope and despair, loss and survival, and countless other emotions."
"We are whole people, comprised of biological, spiritual, emotional and psychological parts," said Richard Payne, M.D., NCCS Chair, and an internationally known expert in the areas of pain relief, care for those near death, oncology and neurology. "Oncology On Canvas recognizes this fact by providing anyone affected by cancer with a platform to express often unspoken emotions, resulting in artwork that moves and inspires."
Call for Entries Details
The 2012 Lilly Oncology On Canvas competition is open to residents of the United States, Puerto Rico and Canada. There are three entrant categories: person diagnosed with cancer; family member, friend or caregiver; and healthcare professional. Original artwork that depicts one's cancer journey may be submitted in one of six media: watercolor, oil, pastel, photography, acrylic or mixed media. The artwork must be accompanied by a narrative.
Winners in 24 categories will be chosen by an independent panel of judges. Prizes consist of donations to cancer-related charities selected by the winners, ranging from $1,000 to $10,000. Following the competition, much of the artwork will embark on a tour of cancer centers, hospitals and patient advocacy group events.
For further information about Lilly Oncology On Canvas, including official rules, entry forms and a gallery of previous entries that will inspire you, visit www.LillyOncologyOnCanvas.com. You may also call 1-866-991-LOOC (5662) or e-mail This e-mail address is being protected from spambots. You need JavaScript enabled to view it. .
You can follow Lilly Oncology On Canvas on Twitter (twitter.com/LlyOncOnCanvas), Facebook (www.facebook.com/LillyOncologyOnCanvas) and YouTube (www.youtube.com/LlyOncOnCanvas). To learn more about cancer survivorship tools and resources, visit the National Coalition for Cancer Survivorship (NCCS) website at www.canceradvocacy.org.
About the National Coalition for Cancer Survivorship
Founded by and for cancer survivors, the National Coalition for Cancer Survivorship (NCCS) advocates for quality cancer care for all people touched by cancer and provides tools and resources that empower people to advocate for themselves. NCCS believes patients empowered with information and tools can receive optimal care by making their needs known to their doctors and care teams. Provided at no cost to the survivor, NCCS offers publications and resources such as the award-winning Cancer Survival Toolbox®, a self-learning audio program created by leading cancer organizations to help people develop essential skills to meet the challenges of their illness. NCCS strongly believes in evidence-based advocacy that reflects the needs of all cancer survivors to affect policy change at the national level. By advocating for patient-centered, coordinated care through treatment planning and care planning, NCCS is ensuring that the needs of cancer survivors remain at the center of healthcare policy. Since 2004, NCCS has been the co-presenter of the Lilly Oncology On Canvas Art Competition and Exhibition. More information is available at www.canceradvocacy.org or 1-888-650-9127.
About Lilly Oncology
For more than four decades, Lilly Oncology, a division of Eli Lilly and Company, has been dedicated to delivering innovative solutions that improve the care of people living with cancer. Because no two cancer patients are alike, Lilly Oncology is committed to developing novel treatment approaches.
About Eli Lilly and Company
Lilly, a leading innovation-driven corporation, is developing a growing portfolio of pharmaceutical products by applying the latest research from its own worldwide laboratories and from collaborations with eminent scientific organizations. Headquartered in Indianapolis, Ind., Lilly provides answers — through medicines and information — for some of the world's most urgent medical needs.
[i] American Cancer Society, Cancer Facts & Figures 2011, http://www.cancer.org/Research/CancerFactsFigures/CancerFactsFigures/cancer-facts-figures-2011. Accessed July 6, 2011.
(Logo: http://www.newscom.com/cgi-bin/prnh/20031219/LLYLOGO )
(Logo: http://photos.prnewswire.com/prnh/20050921/NCCSLOGO )
(Logo: http://photos.prnewswire.com/prnh/20041202/OOCLOGO )
P-LLY
SOURCE Eli Lilly and Company
Related Articles
- New Phase 3 data for Tradjenta® (linagliptin) tablets in black or African American patients with type 2 diabetes showed significant improvement in blood sugar
- American College of Endocrinology (ACE) and Lilly Diabetes Offer New Tips to Help People With Diabetes Prepare for Emergencies
- Lilly Diabetes Presents Phase II Blood Pressure and Heart Rate Data on Investigational GLP-1 Analog Candidate, Dulaglutide, in Patients with Type 2 Diabetes at the 27th American Society of Hypertension Scientific Meeting
- Lilly Applauds Law Enforcement Officials for their Successful Investigation and Recovery of Pharmaceuticals Stolen from Connecticut Distribution Center
- Lilly Sets Date for Lilly Diabetes Pipeline Update to the Investment Community
- DiversityInc Names Lilly a Top Company for Diversity
- Stock Futures Higher on Apple’s Blowout Quarter. Stocks to Watch: AAPL, AN, BIDU, BAC, CAT, CLF, LLY, QCOM, SAP
- Lilly Reports Solid Start to the Year With First-Quarter 2012 Results, Raises EPS Guidance
- Lilly Declares Second-Quarter 2012 Dividend
- Lilly Diabetes and Walgreens Launch Diabetes Hypoglycemia Awareness Campaign
Related Partner Headlines
- Eli Lilly And Company (LLY): Today's Featured Health Care Loser - TheStreet.com
- Eli Lilly And Stock To Go Ex-dividend Tomorrow (LLY) - TheStreet.com
- Diary of a Dividend Diva: Buckle Up - TheStreet.com
- UPDATE: Bank of America Increases PO on Eli Lilly & Co to $46 - Benzinga
- Eli Lilly And Company (LLY): Today's Featured Drugs Winner - TheStreet.com
- Boehringer Ingelheim and Lilly's new oral type 2 diabetes treatment for adults, Jentadueto tablets, now available in U.S. pharmacies - Benzinga
- UPDATE: JP Morgan Upgrades Eli Lilly to Neutral - Benzinga
- Dividend Stocks Will Be Winners for a Whole Decade - TheStreet.com
- Eli Lilly And Stock To Go Ex-dividend Monday (LLY) - TheStreet.com
- New Study Evaluates Cialis in parallel with Tamsulosin in Men with Signs and Symptoms Suggestive of Benign Prostatic Hyperplasia - Benzinga
TradersHuddle Search
| Sponsored By: |
|
Stock Search: |
|
Site Search: Loading
|
Latest Partner Headlines
-
JP Morgan Lowers Australian Economic Growth Estimates - Benzinga -
Stocks To Watch For May 25 - Benzinga -
Top 4 Stocks In The Specialty Eateries Industry With The Highest Cash - Benzinga -
Top 4 Small-Cap Stocks In The Security Software & Services Industry With The Highest ROE - Benzinga -
Top 4 Small-Cap Stocks In The Health Care Plans Industry With The Highest Revenue - Benzinga -
Top 4 Small-Cap Stocks In The Heavy Construction Industry With The Lowest PEG Ratio - Benzinga -
Earnings Scheduled For May 25 - Benzinga -
Cramer's 'Mad Money' Recap: Big Government Not Protecting the Little Guys - TheStreet.com
Stock Market
Dow Jones
Company ID [INDEXDJX:.DJI] Last trade:12,529.75 Trade time:4:05PM EDT Value change:▲33.60 (0.27%)S&P 500
Company ID [INDEXSP:.INX] Last trade:1,320.68 Trade time:4:32PM EDT Value change:▲1.82 (0.14%)NASDAQ
Company ID [INDEXNASDAQ:.IXIC] Last trade:2,839.38 Trade time:5:16PM EDT Value change:▼10.74 (-0.38%)In The Wires
-
Baxter’s Low Glucose PD Solutions Favorably Impacted Metabolic Measures Including Glycemic Control in Trials of Diabetics Undergoing Dialysis -
Score a Hit With FIFA 13 From Tesco Entertainment Online -
Syngenta settles atrazine litigation in the USA -
Atrazine Litigation Settled -
eMazzanti Attains Xerox Gold Partner Status -
USFS, BLM Hire Youth for Public Lands Conservation Jobs -
SCVBank Elects Scott K. Rushing as New Chairman -
Heritage Oaks Bancorp to Pay Trust Preferred Interest and Accumulated TARP Dividends









